Association of Killer Cell Immunoglobulin-like Receptor Genotypes and Haplotypes in Dry Eye Disease Patients Treated with Restasis and Systane

References

• Hsu KC, Chida S, Geraghty DE, et al. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev. 2002;190:40–52. doi:https://doi.org/10.1034/j.1600-065X.2002.19004.x.
   PubMed Web of Science ®Google Scholar
• Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol. 2002;169:5118–5129. doi:https://doi.org/10.4049/jimmunol.169.9.5118.
   PubMed Web of Science ®Google Scholar
• Shilling HG, Young N, Guethlein LA, et al. Genetic control of human NK cell repertoire. J Immunol. 2002;169:239–247. doi:https://doi.org/10.4049/jimmunol.169.1.239.
   PubMed Web of Science ®Google Scholar
• Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics. 2002;54:221–229. doi:https://doi.org/10.1007/s00251-002-0463-7.
   PubMed Web of Science ®Google Scholar
• Zhuang YL, Li XX, Li XH, et al. Association of KIR genotypes and haplotypes in HBeAg-positive chronic hepatitis B patients treated with entecavir. Immunol Invest. 2019;48(4):333–344. doi:https://doi.org/10.1080/08820139.2018.1529791.
   PubMed Web of Science ®Google Scholar
• Sugioka DK, Gonçalves CE, Bicalho MD. KIR repertory in patients with hematopoietic diseases and healthy family members. BMC Hematol. 2016;16:25. doi:https://doi.org/10.1186/s12878-016-0064-6.
   PubMedGoogle Scholar
• Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–412. doi:https://doi.org/10.2147/OPTH.
   PubMedGoogle Scholar
• Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409–415. doi:https://doi.org/10.1016/j.ajo.2006.11.060.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol. 2011;89:965–972. doi:https://doi.org/10.1189/jlb.1110611.
   PubMed Web of Science ®Google Scholar
• Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45:4293–4301. doi:https://doi.org/10.1167/iovs.03-1145.
   PubMed Web of Science ®Google Scholar
• Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283–2292.
   PubMed Web of Science ®Google Scholar
• Yagci A, Gurdal C. The role and treatment of inflammation in dry eye disease. Int Ophthalmol. 2014;34:1291–1301. doi:https://doi.org/10.1007/s10792-014-9969-x.
   PubMed Web of Science ®Google Scholar
• Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol. 2006;298:225–257. doi:https://doi.org/10.1007/3-540-27743-9_12.
   PubMed Web of Science ®Google Scholar
• Sall KN, Cohen SM, Christensen MT, Stein JM. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye. Eye Contact Lens. 2006;32(1):21–26. doi:https://doi.org/10.1097/01.icl.0000170599.57728.29.
   PubMedGoogle Scholar
• Kang M, Kim YH, Chou M, et al. Evaluation of the efficacy and safety of a novel 0.05% cyclosporin a topical nanoemulsion in primary Sj ögren’s syndrome dry eye. Ocul Immunol Inflamm. 2019:1–9. doi:https://doi.org/10.1080/09273948.2019.1587470.
   Google Scholar
• Ren G, Li H, Qiao W, et al. Possible association of killer cell immunoglobulin-like receptor genotypes and haplotypes with dry eye disease in a Han Chinese population. Mol Vis. 2015;21:948–954.
   PubMed Web of Science ®Google Scholar
• Zhuang YL, Song Y, Zhu C, et al. Association of KIR genotypes and haplotypes with syphilis in a Chinese Han population. Scand J Immunol. 2012;75(3):361–367. doi:https://doi.org/10.1111/j.1365-3083.2011.02664.x.
   PubMed Web of Science ®Google Scholar
• Dogru M, Tsubota K. New insights into the diagnosis and treatment of dry eye. Ocul Surf. 2004;2(2):59–75. doi:https://doi.org/10.1016/S1542-0124(12)70145-3.
   PubMedGoogle Scholar
• Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev. 2006;214:186–201. doi:https://doi.org/10.1111/imr.2006.214.issue-1.
   PubMed Web of Science ®Google Scholar
• Byun YS, Rho CR, Cho K, Choi JA, Na KS, Joo CK. Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study. Korean J Ophthalmol. 2011;25(6):69–374. doi:https://doi.org/10.3341/kjo.2011.25.6.369.
   PubMedGoogle Scholar
• Christensen MT, Cohen SM, Rinehart J, et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res. 2004;28:55–62. doi:https://doi.org/10.1076/ceyr.28.1.55.23495.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol. 2008;20:343–352. doi:https://doi.org/10.1016/j.smim.2008.06.003.
   PubMed Web of Science ®Google Scholar
• Majorczyk E, Pawlik A, Gendosz D, Kuśnierczyk P. Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment. BMC Musculoskelet Disord. 2014;15:256. doi:https://doi.org/10.1186/1471-2474-15-256.
   PubMed Web of Science ®Google Scholar
• Nowak I, Magott-Procelewska M, Kowal A, et al. Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation. PLoS One. 2012;7(9):e44718. doi:https://doi.org/10.1371/journal.pone.0044718.
   PubMed Web of Science ®Google Scholar
• Zhou J, Tang X, Ding Y, An Y, Zhao X. Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis. Pediatr Allergy Immunol. 2013;24(7):691–696. doi:https://doi.org/10.1111/pai.2013.24.issue-7.
   PubMed Web of Science ®Google Scholar
• Giebel S, Nowak I, Wojnar J, et al. Association of KIR2DS4 and its variant KIR1D with leukemia. Leukemia. 2008;22(11):2129–2130. doi:https://doi.org/10.1038/leu.2008.108.
   PubMed Web of Science ®Google Scholar
• Zhuang YL, Zhu CF, Zhang Y, et al. Association of KIR2DS4 and its variant KIR1D with syphilis in a Chinese Han population. Int J Immunogenet. 2012;39(2):114–118. doi:https://doi.org/10.1111/j.1744-313X.2011.01063.x.
   PubMed Web of Science ®Google Scholar
• Middleton D, Gonzalez A, Gilmore PM. Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum Immunol. 2007;68(2):128–134. doi:https://doi.org/10.1016/j.humimm.2006.12.007.
   PubMed Web of Science ®Google Scholar
• Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol. 2004;173:4273–4276. doi:https://doi.org/10.4049/jimmunol.173.7.4273.
   PubMed Web of Science ®Google Scholar